(Q33419781)

26 July 2017

Neuromyelitis optica in Brazil: a study on clinical and prognostic factors (English)

1 reference

26 July 2017

0 references

1 reference

D B Bichuetti

1

1 reference

26 July 2017

E M L Oliveira

2

1 reference

26 July 2017

N A Souza

3

1 reference

26 July 2017

R L M Rivero

4

1 reference

26 July 2017

A A Gabbai

5

1 reference

26 July 2017

19 March 2009

1 reference

Multiple Sclerosis Journal

26 July 2017

1 reference

26 July 2017

15

1 reference

26 July 2017

5

1 reference

26 July 2017

613-619

1 reference

Neuromyelitis optica: changing concepts

26 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Devic's neuromyelitis optica: clinical features and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Natural history of the visual impairment of relapsing neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Age at disability milestones in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Devic's neuromyelitis optica: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Diagnosis and treatment of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Optic neuromyelitis syndrome in Brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

NMO-IgG and Devic's neuromyelitis optica: a French experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Characteristics of Devic's disease (neuromyelitis optica) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

NMO-IgG in the diagnosis of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

Clinical course of optic neuritis in patients with relapsing neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508101935

21 January 2018

Identifiers

DOI

10.1177/1352458508101935

1 reference

26 July 2017

1 reference